Major PBM Looks to Stem Gilead Sciences' (GILD) Hepatitis C Profits
Go back to Major PBM Looks to Stem Gilead Sciences' (GILD) Hepatitis C Profits| Express Scripts (NASDAQ: ESRX) | Delayed: 92.33 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.33 | 52 Week High | $89.00 | |||
| Open | $0.01 | 52 Week Low | $64.46 | |||
| Day High | $92.33 | P/E | 39.97 | |||
| Day Low | $92.33 | EPS | $2.31 | |||
| Volume | 0 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 151.00 -0.22 (0.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $151.22 | 52 Week High | $108.63 | |||
| Open | $149.23 | 52 Week Low | $71.39 | |||
| Day High | $151.19 | P/E | 83.43 | |||
| Day Low | $149.23 | EPS | $1.81 | |||
| Volume | 5,937,118 | |||||

